SERUM IMMUNOGLOBULIN CONCENTRATIONS IN PATIENTS FOLLOWING BONE-MARROW TRANSPLANT AND PROPHYLACTIC ADMINISTRATION OF HIGH-DOSE UNSPECIFIC OR NORMAL-DOSE CMV-SPECIFIC IMMUNOGLOBULIN

被引：0
|
作者：
BERGER, C
GRATWOHL, A
DORAN, JE
SCHERZ, R
BAUMGARTNER, C
MORELL, A
BACHMANN, B
SPAETH, PJ
TICHELLI, A
SPECK, B
机构：
来源：
TRANSFUSION MEDICINE 1988 - INFECTIONS, PLASMA PRODUCTS, TRANSPLANTATIONS, ANTIBODIES | 1989年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：112 / 121
页数：10
相关论文
共 50 条
  • [1] HIGH-DOSE IMMUNOGLOBULIN TREATMENT IN AUTOLOGOUS BONE-MARROW TRANSPLANTATION ]BMT)
    LAMBERTENGHIDELILIERS, G
    BENAZZI, E
    MOZZANA, R
    ZOCCHI, L
    POLLI, EE
    INTERNATIONAL JOURNAL OF CELL CLONING, 1985, 3 (04): : 272 - 273
  • [2] CYTOMEGALOVIRUS (CMV) INDUCED PANCYTOPENIA IN ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) RECIPIENTS PROPHYLAXED WITH HIGH-DOSE ACYCLOVIR AND INTRAVENOUS IMMUNOGLOBULIN (IV IG)
    ASCENSAO, JL
    BILGRAMI, S
    QUINN, JJ
    ALMEIDA, MG
    TUCK, D
    BERGSTROM, S
    SHANLEY, J
    DAINIAK, N
    DORSKY, D
    POLIQUIN, C
    EXPERIMENTAL HEMATOLOGY, 1992, 20 (06) : 710 - 710
  • [3] MACROPHAGE-MEGAKARYOCYTE INTERACTION IN BONE-MARROW AFTER HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN THERAPY
    SAITO, N
    TAKEMORI, N
    HIRAI, K
    ONODERA, R
    WATANABE, S
    NAMIKI, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1993, 44 (03) : 201 - 203
  • [4] Neutropenias following allogeneic bone marrow transplantation: Response to therapy with high-dose intravenous immunoglobulin
    Khouri, IF
    Ippoliti, C
    Gajewski, J
    Przepiorka, D
    Champlin, RE
    AMERICAN JOURNAL OF HEMATOLOGY, 1996, 52 (04) : 313 - 315
  • [5] BONE-MARROW TRANSPLANTATION FOLLOWING TREATMENT WITH HIGH-DOSE MELPHALAN
    DALE, BM
    SAGE, RE
    NORMAN, JE
    BARBER, S
    KOTASEK, D
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (02) : 1711 - 1713
  • [6] HIGH-DOSE CHEMOTHERAPY AS CONDITIONING REGIMEN FOR ALLOGENEIC BONE-MARROW TRANSPLANT
    ZANDER, AR
    CULBERT, S
    VELLEKOOP, L
    JAGANNATH, S
    SPITZER, G
    DICKE, KA
    BLUT, 1984, 49 (03): : 294 - 295
  • [7] CYCLOPHOSPHAMIDE AND PHOSPHORAMIDE MUSTARD - HOW ARE THEY RELATED IN HIGH-DOSE BONE-MARROW TRANSPLANT PATIENTS
    HARDY, R
    MOORE, M
    THIESSEN, J
    ERLICHMAN, C
    SOLDIN, S
    CLINICAL CHEMISTRY, 1987, 33 (06) : 1035 - 1035
  • [8] HIGH-DOSE WEEKLY INTRAVENOUS IMMUNOGLOBULIN TO PREVENT INFECTIONS IN PATIENTS UNDERGOING AUTOLOGOUS BONE-MARROW TRANSPLANTATION OR SEVERE MYELOSUPPRESSIVE THERAPY - A STUDY OF THE AMERICAN-BONE-MARROW-TRANSPLANT-GROUP
    WOLFF, SN
    FAY, JW
    HERZIG, RH
    GREER, JP
    DUMMER, S
    BROWN, RA
    COLLINS, RH
    STEVENS, DA
    HERZIG, GP
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (12) : 937 - 942
  • [9] ACUTE INTRAVASCULAR HEMOLYSIS ASSOCIATED WITH HIGH-DOSE IMMUNOGLOBULIN AFTER BONE-MARROW TRANSPLANTATION FOR ACUTE MYELOGENOUS LEUKEMIA
    ROVELLI, A
    DANGELO, P
    BALDUZZI, A
    BORZINI, P
    BIONDI, A
    UDERZO, C
    LEUKEMIA & LYMPHOMA, 1991, 5 (01) : 71 - 74
  • [10] PHARMACOKINETICS OF CYTOMEGALO-VIRUS SPECIFIC IGG ANTIBODY FOLLOWING INTRAVENOUS IMMUNOGLOBULIN IN BONE-MARROW TRANSPLANT PATIENTS
    RAND, KH
    HOUCK, H
    GANJU, A
    BABINGTON, RG
    ELFENBEIN, GJ
    BONE MARROW TRANSPLANTATION, 1989, 4 (06) : 679 - 683
12345